z-logo
open-access-imgOpen Access
Spironolactone alleviates myocardial fibrosis via inhibition of Ets‑1 in mice with experimental autoimmune myocarditis
Author(s) -
Wenke Wang,
Ben Wang,
Xue-Hu Cao,
Yusheng Liu
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11296
Subject(s) - myocardial fibrosis , spironolactone , fibrosis , cardiac fibrosis , myocarditis , medicine , endocrinology , cardiac function curve , mineralocorticoid receptor , inflammation , smad , heart failure , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom